RS57850B1 - Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies - Google Patents

Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Info

Publication number
RS57850B1
RS57850B1 RS20181308A RSP20181308A RS57850B1 RS 57850 B1 RS57850 B1 RS 57850B1 RS 20181308 A RS20181308 A RS 20181308A RS P20181308 A RSP20181308 A RS P20181308A RS 57850 B1 RS57850 B1 RS 57850B1
Authority
RS
Serbia
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
RS20181308A
Other languages
Serbian (sr)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from EP11770625.9A external-priority patent/EP2624865B1/en
Publication of RS57850B1 publication Critical patent/RS57850B1/en

Links

RS20181308A 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies RS57850B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
RS57850B1 true RS57850B1 (en) 2018-12-31

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181308A RS57850B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Country Status (13)

Country Link
AR (1) AR083338A1 (en)
DK (2) DK2624865T3 (en)
ES (2) ES2820246T3 (en)
HK (1) HK1258305A1 (en)
HR (1) HRP20181822T1 (en)
HU (1) HUE052089T2 (en)
LT (1) LT2624865T (en)
PT (1) PT3354280T (en)
RS (1) RS57850B1 (en)
SI (1) SI2624865T1 (en)
TW (6) TWI718890B (en)
UA (1) UA111731C2 (en)
UY (1) UY33652A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201500889TA (en) 2012-08-21 2015-03-30 Sanofi Sa Methods for treating or preventing asthma by administering an il-4r antagonist
TWI709411B (en) * 2013-06-21 2020-11-11 法商賽諾菲生物技術公司 Use of an il-4r antagonist for the manufacture of a medicament for treating nasal polyposis
HUE046410T2 (en) * 2013-06-21 2020-03-30 Sanofi Biotechnology Methods for treating nasal polyposis by administering an il-4r antagonist
EP3218412A1 (en) 2014-11-14 2017-09-20 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
PL3703818T3 (en) 2017-10-30 2024-03-25 Sanofi Biotechnology Il-4r antagonist for use in a method for treating or preventing asthma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (en) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% PATTERN ALIGNMENT SYSTEM IN A SUBSTRATE BY LITOGRAPHY BY ESTENCIL.
WO2010029664A1 (en) * 2008-09-10 2010-03-18 日本エクスラン工業株式会社 Crosslinked acrylate-based fibers and the production thereof
BRPI1006519A2 (en) * 2009-03-06 2016-08-09 Genentech Inc antibody formulation

Also Published As

Publication number Publication date
TW201716086A (en) 2017-05-16
TWI679988B (en) 2019-12-21
TWI782325B (en) 2022-11-01
TWI690329B (en) 2020-04-11
DK3354280T3 (en) 2020-09-28
DK2624865T3 (en) 2018-10-22
UY33652A (en) 2012-04-30
TW202320851A (en) 2023-06-01
ES2820246T3 (en) 2021-04-20
UA111731C2 (en) 2016-06-10
LT2624865T (en) 2018-10-25
SI2624865T1 (en) 2018-10-30
TW202026011A (en) 2020-07-16
PT3354280T (en) 2020-09-01
HRP20181822T1 (en) 2018-12-28
TW202102262A (en) 2021-01-16
ES2687813T3 (en) 2018-10-29
HK1258305A1 (en) 2019-11-08
TW201542229A (en) 2015-11-16
TW201924718A (en) 2019-07-01
AR083338A1 (en) 2013-02-21
TWI568445B (en) 2017-02-01
TWI498121B (en) 2015-09-01
TW201221141A (en) 2012-06-01
HUE052089T2 (en) 2021-04-28
TWI718890B (en) 2021-02-11

Similar Documents

Publication Publication Date Title
IL283424A (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
HRP20181821T1 (en) Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
IL265501A (en) Stabilized antibody-containing liquid formulations
SI3409289T1 (en) Stable antibody containing compositions
HK1258305A1 (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
EP2588141A4 (en) Antibody formulations